Melanocortin Research

Melanocortin research peptides occupy a distinct niche in neuropeptide pharmacology, studied for their interactions with the central melanocortin system — a network of receptors and signaling pathways distributed across the hypothalamus, limbic system, and brainstem. Unlike hormone-based approaches to melanocortin pathway research, compounds in this category act primarily on melanocortin receptor subtypes (MC3R, MC4R, MC5R) rather than peripheral hormonal axes, making them valuable tools for studying central nervous system melanocortin signaling mechanisms. Research interest in melanocortin agonists has expanded alongside broader work in neuropeptide pharmacology and hypothalamic circuit biology. All compounds are supplied as lyophilized, research-grade material for laboratory use only.

Compounds in This Category

PT-141 (Bremelanotide) — PT-141 is a selective melanocortin receptor agonist with preferential activity at MC4R, a receptor subtype expressed throughout the hypothalamus and limbic system. Unlike peripherally-acting compounds, PT-141 exerts its studied effects via central nervous system pathways, making it a valuable research tool for investigating CNS-mediated melanocortin signaling and the role of MC4R in hypothalamic-limbic circuit modulation. PT-141 is available here in 10mg lyophilized vials for melanocortin receptor pharmacology research.

MT-II (Melanotan-II) — Melanotan-II is a non-selective cyclic melanocortin agonist with activity across MC1R, MC3R, MC4R, and MC5R. Its broader receptor profile relative to PT-141 makes it a useful comparative tool in receptor selectivity research — allowing researchers to dissect the contributions of individual receptor subtypes to observed downstream effects. See our PT-141 vs MT-II comparison guide for a detailed side-by-side. MT-II is studied across multiple domains including melanocortin pathway pharmacology, skin pigmentation research via MC1R activation, and CNS melanocortin receptor models. This multi-receptor activity profile has established Melanotan-II as a reference compound in melanocortin system research.

Research Applications

Researchers studying the melanocortin system have applied these compounds across a range of CNS and pharmacological model systems. Common applications include melanocortin receptor pharmacology and binding studies characterizing MC3R, MC4R, and MC5R activity; central nervous system research investigating hypothalamic and limbic melanocortin pathway signaling; neuropeptide signaling studies exploring melanocortin agonism in autonomic and neuroendocrine regulation; skin pigmentation research using MT-II’s MC1R activity as a model for melanocyte stimulation; and receptor selectivity studies using PT-141 and Melanotan-II as comparative tools to isolate subtype-specific downstream effects.

Documentation

Documentation availability varies by product and tested sample. Where third-party testing has been completed, Certificates of Analysis are linked directly from the individual product page — review the attached report for the exact product or formulation, since some products or vial sizes may not have matching analytical documentation. See our guide to reading a Certificate of Analysis for what each section does and doesn’t confirm. Products are supplied in lyophilized form for optimal shelf stability and shipped with secure, temperature-appropriate packaging from our Pacific Northwest facility.

Storage & Handling

Lyophilized melanocortin research peptides should be stored at −20°C and shielded from light and humidity prior to reconstitution. For detailed storage protocols and reconstitution procedures, see the Peptide Storage & Handling Guide, or browse the full Research Hub for additional compound guides.

All compounds are sold strictly for research and laboratory use only. Not intended for human consumption, diagnosis, or treatment of any condition.